|
Research efforts leading to a better understanding of biological rhythms
will have a broad influence on all aspects of health and the treatment
of disease. Twenty-four hour and seasonal rhythms are fundamental features
of all forms of life, reflecting the adaptation of life to dominant features
of the earths environment. Our daily 24-hour routines, including
the sleep/wake cycle, are controlled by a complex neural system that has
an endogenous master circadian oscillator and an important output signal,
melatonin, the hormone of time. Light acts on this system to entrain the
endogenous clock with environmental lighting. Circulating melatonin is
produced in the pineal gland and is always elevated at night. Our primary
objective is to advance our knowledge of vertebrate chronobiology and
neuroendocrinology. Our efforts focus on understanding the regulation
of the daily rhythm in melatonin production, which plays an essential
role in mental health and in timing seasonal and circadian biology. Melatonin
is used in humans with the intention of improving the entrainment of the
biological clock in the blind and in individuals suffering from jet
lag resulting from shift work and travel.
Post-Translational Regulation of the Melatonin
Rhythm Enzyme: Arylalkylamine N-Acetyltransferase
Klein, Coon, Gaildrat, Ganguly, Morin, Kim, Weller;
in collaboration with Aitken, Boutin, Cole, Zhen, Dyda, Hickman, Obsil,
Falcón, Ho, Chik, Iuvone, Jaffe, Korf, Schomerus, Malpaux, Chemineau,
Markey, Kowalak, Ron, Toyama, Dawid, Young
The enzyme that drives the day/night rhythm in melatonin production is
arylalkylamine Nacetyltransferase (AANAT). Many regulatory mechanisms
converge on this enzyme. Our studies have provided evidence for at least
three post-translational mechanisms involved in cyclic AMP regulation
of AANAT activity: phosphorylation-dependent prevention of proteolytic
destruction, phosphorylation-dependent allosteric effects, and uncharacterized
events that activate the protein without altering the phosphorylation
state of AANAT. A highly conserved mechanism involved in regulating AANAT
activity is prevention of proteolysis. Studies of several species, representing
three vertebrate classes, have pointed to a close association between
changes in AANAT activity and AANAT protein levels. We prepared antisera
against AANAT from ungulates, primates, rodents, chicken, and fish. In
all cases, the antisera demonstrated a close association between large
changes in AANAT protein and activity, including the large in
vivo day/night changes and the rapid reductions that occur when
lights are turned on in the middle of the night. We established that the
rapid decrease in AANAT protein is due to proteolysis by the proteasome,
an extremely rapid and irreversible mechanism that turns off melatonin
production, a mechanism that is regulated by cyclic AMP.
AANAT is typically phosphorylated in the cell. A hunt for phosphorylation-dependent
AANAT binding identified 14-3-3 proteins. The binding to AANAT is triggered
by phosphorylation of at least one and probably both PKA sites on the
enzyme. The N-terminal PKA site is located in a sequence that becomes
a consensus 14-3-3 binding motif upon phosphorylation (RRHTPLAN
RRHpTPLAN). Crystallo-graphic analysis of the AANAT/14-3-3
complex revealed that the PKA/14-3-3 motif forms multiple contacts with
residues in the amphipathic binding groove of 14-3-3, which allowed us
to propose a simple model of the complex. Other studies revealed that
the binding could be disrupted by using a 16-residue peptide containing
the PKA/14-3-3 binding motif. Although the 14-3-3/AANAT complex has been
studied only in the ovine pineal gland, it is probable that, given the
highly conserved nature of the PKA/14-3-3 binding motif of AANAT and the
ubiquitous presence and highly conserved structure of 14-3-3 proteins,
AANAT exists in this form in all vertebrates. In accordance with evidence
that 14-3-3 prevents dephosphorylation by a phosphatase and clipping of
the N-terminal tail by a protease, the mechanism through which proteolysis
of AANAT is regulated appears to involve shielding by 14-3-3.
Phosphorylation-dependent binding of AANAT to 14-3-3 protein not only
protects against proteolysis but also activates AANAT by increasing the
affinity of AANAT for serotonin. Analysis of the crystal structures of
AANAT, obtained with and without a bisubstrate inhibitor, indicates that
a region of AANAT known as Loop 1 is involved in this allosteric effect.
14-3-3 stabilizes Loop 1 in a configuration that favors catalysis in general
and strongly influences serotonin binding, causing a 10-fold increase
in the affinity of the enzyme for serotonin. We created cell lines expressing
Aanat and used them to study the effect
of the level and phosphoryla-tion state of the enzyme on its function.
Intracellular acetylation was activated by elevation of cyclic AMP levels
without changing total AANAT protein, pointing to the effects of cyclic
AMP on other factors involved in acetylation, such as the availability
of AcCoA.
Pineal/Retinal Tissue-Specific Gene Expression
Klein, Coon, Shi, Weller; in collaboration with
Baler, Carter, Humphries, Falcón, Gothilf, Ron, Toyama, Dawid
The pineal expresses an unusual set of genes, some of which are expressed
in only one other tissue: the retina. To determine the molecular events
involved in directing tissue-specific expression of these genes, we used
regions of the rat and zebra fish Aanat promoter, first, to insert genes
of interest into the pineal gland, which has allowed us to characterize
promoters that drive expression in the pineal gland in both animals, and,
second, to study the effects of over-expression of genes of interest.
To probe the function of Fra-2, which is induced in coordination with
AANAT in the rodent pineal gland, we developed a construct that knocks
down expression of the transcription factor Fra2 the rat. However, the
knockdown does not alter induction of AANAT. Work in zebrafish has led
to the development of a line of fish that expresses the green fluorescent
protein reporter gene in the pineal gland under control of 3' and 5' elements
of the AANAT gene flanking the open reading frame. The line has potential
use in analysis of the factors that regulate the developmental expression
of the AANAT gene.
Evolution of AANAT
Klein, Coon, Shi; in collaboration with Falcón,
Gothilf, Koonin
The discovery of two AANAT enzymes in fish triggered interest in the possibility
that two genes exist in other vertebrates. We have so far failed to find
evidence of a second AANAT in any vertebrate other than fish. Duplication
of the fish genome appears to have occurred following the emergence of
fish from the evolutionary line leading to higher vertebrates and to have
allowed distinctly different enzymes to evolve in fish, with different
kinetic characteristics, and, in some species, remarkable differences
in tissue distribution. In trout, one Aanat
gene is expressed in the pineal (Aanat-2)
and the other in the retina (Aanat-1).
Regulatory differences have also evolved; in the trout pineal gland, AANAT
is high at night and suppressed by light, as seen in all vertebrates,
but light increases AANAT in the trout retina. These differences may have
evolved to meet the different pressures on melatonin function in the pineal
gland (hormonal signal of time) as compared with that in the retina (paracrine
control of photosensitivity).
Transcriptional Control of Aanat
Klein, Coon, Weller; in collaboration with Baler,
Blackshaw, Carter, Humphries, Chong, Iuvone
Although post-translational mechanisms play an important role in regulating
AANAT activity and protein levels, the abundance of mRNA encoding the
enzyme is controlled in some vertebrates. For example, day/night changes
in AANAT mRNA are large in birds and rodents, whereas day/night AANAT
mRNA levels are similar in trout, sheep, cows, and primates. Thus, we
have studied transcriptional control of AANAT by Fra-2, a transcription
factor that has been thought to control expression of AANAT in the rat.
The AANAT promoter has been used as a vehicle to confer pineal- and retinal-specific
expression of genes. A genetically engineered rat has been produced in
which Fra-2 protein is knocked down. However, suppression of Fra-2 does
not alter AANAT expression, although it was found to influence expression
of the orphan receptor NGFI-B (Nur77/TR3), a member of a nuclear hormone
receptor subfamily that includes the related factors Nurr1 and NOR-1.
This finding has opened new opportunities to examine the role that NGFI-B
plays in biology and the role that Fra-2 plays in regulating this gene.
Research on chicken Aanat has identified
an E-box element, which mediates circadian expression of some clock-controlled
genes such as the AANAT gene. Other studies establish that the circadian
clock in the chicken pineal gland is directly linked to Aanat
by transcription factors that are part of the molecular machinery that
makes up the biological circadian clock, providing a direct link from
the clock to chicken Aanat.
Primate Retinal Melatonin Synthesis
Klein, Coon, Weller; in collaboration with Young
We maintain an interest in the regulation of melatonin in the human pineal
gland and have used the rhesus pineal gland and retina as models of the
human tissues, making it was possible to study elements of the serotonin-to-melatonin
pathway. As is the case in all vertebrates, the activity and protein levels
of AANAT in the pineal and retina were elevated at night. However, as
discussed above, there were no day/night differences in AANAT mRNA, indicating
that AANAT activity is regulated in primates at a post-translational site,
probably by the binding of 14-3-3 proteins. A striking finding was that
HIOMT mRNA was low or undetectable in the retina, consistent with previous
studies on post mortem human retinae and the bovine retina. Such low levels
in the primate retina suggest that AANAT may not be dedicated to melatonin
production and might have a somewhat different role in the retina, such
as in the synthesis of Nacetylserotonin, which may act in place of melatonin
as a ligand for melatonin receptors. Alternatively, N-acetylserotonin
may have an anti-oxidant role. Another possible role for AANAT is that
it acts to prevent the accumulation of toxic derivatives of aromatic amines.
Pineal Protein Hunt
Klein, Coon, Gaildrat, Ganguly, Morin, Kim, Weller;
in collaboration with Baler, Blackshaw, Carter, Humphries, Malpaux, Chemineau,
Markey, Kowalak
With the goal of defining a map of signal transduction and metabolic networks
that describe pineal function, we are constructing a comprehensive list
of proteins that are of special importance to pineal function. More specifically,
we are working toward identifying and characterizing proteins that bind
to AANAT in order to develop a better understanding of AANATs regulation.
Fabrice Morin undertook protein-protein interaction screens of an ovine
pineal cDNA library in yeast by using AANAT as the bait (yeast two-hybrid
screen). The work revealed an interaction between AANAT and an enzyme
that makes AcCoA, ATP-dependent citrate lyase (ACL). ACL was highly expressed
in the pineal gland compared with other tissues and exhibited a day/night
difference in phosphorylation state. Preliminary studies suggest that
ACL and AANAT associate in the ovine pineal gland and that AcCoA generated
by the ACL is preferentially channeled to AANAT. Two collaborations used
gene chips/microarrays as a first step toward identifying pineal proteins
that exhibit large day/night changes that are photically regulated and
that are highly expressed in the pineal gland. With commercially available
chips, we found a rhythm in the transcription factor Id1. We hope to characterize
fully the rhythm in NGFI-B protein and, using microarray technology, to
analyze the expression of genes in animals in which expression of Fra-2
was knocked down selectively in the pineal gland and retina. We are also
using custom chips containing probes for genes expressed by retinal cones,
brain genes, and ESTs from pineal and retinal libraries. With these, we
have been able to detect daily rhythms in mRNA encoding the S-adenosylmethioninesynthesizing
enzyme, methionine adenosyl transferase (MAT), and adrenergic regulation
of MAT mRNA, with high levels occurring at night, which is when the demand
for Sadenosylmethionine is highest.
|
|
SELECTED PUBLICATIONS
- Coon SL, del Olmo E, Young WS, Klein DC. Melatonin synthesis enzymes
in a non-human primate pineal gland: focus on Rhesus arylalkylamine
N-acetyltransferase (EC 2.3.1.87). J Clin Endocrinol Metab. 2002;87:4699-4706.
- Coon SL, Weller JL, Korf HW, Namboodiri MAA, Rollag M, Klein DC.
cAMP regulation of arylalkylamine N-acetyltransferase
(AANAT, EC 2.3.1.87): a new cell line (1E7) provides evidence of intracellular
AANAT activation. J Biol Chem. 2001;276:24097-24107.
- Falcón J, Gallarneau K, Coon SL, Weller JL, Ron B, Chen G,
Klein DC. Regulation of arylalkylamine N-aceytltransferase-2 (AANAT2,
2.3.1.87) in the fish pineal organ: evidence for a role of proteasomal
proteosomal proteolysis. Endocrinology. 2001;142:1804-1813.
- Ganguly S, Coon SL, Klein DC. Control of melatonin synthesis in the
mammalian pineal gland. Cell Tissue Res. 2002;309:127-137.
- Ganguly S, Gastel J, Weller JL, Schwartz C, Jaffe H, Namboodiri MAA,
Coon SL, Hickman AB, Rollag M, Obsi T, Beauverger P, Ferry G, Boutin
JA, Klein DC. Role of a pineal cAMP-operated arylalkylamine N-acetyltransferase/14-3-3
binding switch in melatonin synthesis. Proc Natl Acad Sci USA. 2001;98:8083-8088.
- Ganguly S, Mummaneni P, Steinbach PJ, Klein DC, Coon SL. Characterization
of the Saccharomyces cerevisiae homolog
of the melatonin rhythm enzyme arylalkylamine N-acetyltransferase
(AANAT, EC 2.3.1.87). J Biol Chem. 2001;276:47239-47247.
- Gothilf Y, Toyama R, Coon SL, Du SJ, Dawid IB, Klein DC. Pineal-specific
expression of green fluorescent protein under the control of the serotonin-N-acetyltransferase
gene regulatory regions in transgenic zebrafish. Dev Dynam. 2002;225:241-249.
- Humphries A, Klein DC, Baler R, Carter DA. cDNA array analysis of
pineal gene expression reveals circadian rhythmicity of the dominant
negative helix-loop-helix protein-encoding gene, Id-1. J Neuroendocrinol.
2002;14:101-108.
- Iuvone PM, Brown AD, Haque R, Weller JL, Zawilska JB, Chaurasia SS,
Ma MH, Klein DC. Retinal melatonin production: role of proteasomal proteolysis
in circadian and photic control of arylalkylamine N-acetyltransferase.
Invest Opthalmol Vis Sci. 2002;43:564-572.
- Klein DC, Ganguly S, Coon SL, Weller JL, Obsil T, Hickman A, Dyda
F. 14-3-3 proteins and photoneuroendocrine transduction: role in controlling
the daily rhythm in melatonin. Biochem Soc Trans. 2002;30:365-372.
- Obsil T, Ghirlando R, Klein DC, Ganguly S, Dyda F. Crystal structure
of the 14-3-3z:serotonin N-acetyltransferase
complex: a role for scaffolding in enzyme regulation. Cell 2001;105:257-267.
- Smith M, Burke Z, Humphries A, Wells T, Klein DC, Carter D, Baler
R. Tissue specific transgenic knock-down of fos
related antigen-2 (Fra-2) expression mediated by dominant negative Fra-2.
Mol Cell Biol. 2001;21:3704-3713.
COLLABORATORS
Alastair Aitken, Ph.D., University of Edinburgh,
Edinburgh, UK
Ruben Baler, Ph.D., Laboratory of Cellular and
Molecular Regulation, NIMH, Bethesda, MD
Seth Blackshaw, Ph.D., Harvard Medical School,
Cambridge, MA
Jean Boutin, Ph.D., Institut de Recherches Internationales
Servier, Paris, France
David Carter, Ph.D., University of Wales, Cardiff,
UK
Philippe Chemineau, Ph.D., INRS, Nouzilly, France
Constance L. Chik, M.D., University of Alberta,
Edmonton, Alberta, Canada
Nelson Chong, Ph.D., University of Leicester,
Leicester, UK
Philip Cole, M.D., Ph.D., The Johns Hopkins University,
Baltimore, MD
Igor Dawid, Ph.D., Laboratory of Molecular Genetics,
NICHD, Bethesda, MD
Fred Dyda, Ph.D., Laboratory of Molecular Biology,
NIDDK, Bethesda, MD
Jack Falcón, Ph.D., CNRS, Université
Curie, Banyuls sur Mer, France
Yoav Gothilf, Ph.D., Tel Aviv University, Tel
Aviv, Israel
Allison Hickman, Ph.D., Laboratory of Molecular
Biology, NIDDK, Bethesda, MD
Anthony Ho, Ph.D., University of Alberta, Edmonton,
Alberta, Canada
Ann Humphries, Ph.D., University of Wales, Cardiff,
UK
P. Michael Iuvone, Ph.D., Emory University School
of Medicine, Atlanta, GA
Howard Jaffe, Ph.D., Laboratory of Neurochemistry,
NINDS, Bethesda, MD
Eugene V. Koonin, Ph.D., National Center for Biotechnology
Information, NLM, Bethesda, MD
Horst W. Korf, Ph.D., J. W. Goethe Universität,
Frankfurt, Germany
Jeff Kowalak, Ph.D., Laboratory of Neurotoxicology,
NIMH, Bethesda, MD
Benoit Malpaux , Ph.D., INRS, Nouzilly, France
Sandford Markey, Ph.D., Laboratory of Neurotoxicology,
NIMH, Bethesda, MD
Tomas Obsil, Ph.D., Laboratory of Molecular Biology,
NIDDK, Bethesda, MD
Benjamin Ron, Ph.D., Israel Oceanographic and
Limnological Research Ltd., Eilat, Israel
Christof Schomerus, Ph.D., J.W. Goethe Universität,
Frankfurt, Germany
Reiko Toyama, Ph.D., Laboratory of Molecular Genetics,
NICHD, Bethesda, MD
Scott Young, M.D., Ph.D., Laboratory of Cellular
and Molecular Regulation, NIMH, Bethesda, MD
Weiping Zhen, Ph.D., The Johns Hopkins University,
Baltimore, MD
|